Analyzing Charlie’s (CHUC) & The Competition

Posted by on Apr 28th, 2023

Charlie’s (OTCMKTS:CHUC – Get Rating) is one of 59 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its rivals? We will compare Charlie’s to similar businesses based on the strength of its institutional ownership, analyst recommendations, dividends, earnings, valuation, risk and profitability.

Earnings & Valuation

This table compares Charlie’s and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Charlie’s $26.42 million -$1.59 million -9.15
Charlie’s Competitors $280.35 million -$102.05 million -4.75

Charlie’s’ rivals have higher revenue, but lower earnings than Charlie’s. Charlie’s is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

12.3% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 50.5% of Charlie’s shares are held by company insiders. Comparatively, 23.5% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for Charlie’s and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charlie’s 0 0 0 0 N/A
Charlie’s Competitors 211 563 808 43 2.42

As a group, “Medicinals & botanicals” companies have a potential upside of 98.62%. Given Charlie’s’ rivals higher probable upside, analysts plainly believe Charlie’s has less favorable growth aspects than its rivals.

Risk & Volatility

Charlie’s has a beta of 4.66, meaning that its share price is 366% more volatile than the S&P 500. Comparatively, Charlie’s’ rivals have a beta of 1.14, meaning that their average share price is 14% more volatile than the S&P 500.

Profitability

This table compares Charlie’s and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Charlie’s -6.02% -51.60% -17.95%
Charlie’s Competitors -11.17% -83.02% 22.50%

About Charlie’s

(Get Rating)

Charlies Holdings, Inc. offers nicotine-only, e-cigarette and hemp-derived, CBD wellness liquid spaces through its subsidiary companies, Charlie’s Chalk Dust LLC and Don Polly LLC. It offers its products under the Pachamama and Charlie’s Chalk Dust brands. The company was founded by Brandon Stump and Ryan Stump in January 2001 and is headquartered in Costa Mesa, CA.

Receive News & Ratings for Charlie's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charlie's and related companies with MarketBeat.com's FREE daily email newsletter.